Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

PHARMACEUTICALS

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Sodium alendronate 3H2O EP

Sodium alendronate 3H2O EP

121268-17-5

DISCOVER
SULFAMETHIZOLE CRS (100 MG)

SULFAMETHIZOLE CRS (100 MG)

144-82-1

DISCOVER
Sucrose EP

Sucrose EP

57-50-1

DISCOVER
SULFAMETHOXAZOLE CRS (50 MG)

SULFAMETHOXAZOLE CRS (50 MG)

723-46-6

DISCOVER
Sulfadiazine EP

Sulfadiazine EP

68-35-9

DISCOVER
SULFAMETHOXYPYRIDAZINE CRS (50 MG)

SULFAMETHOXYPYRIDAZINE CRS (50 MG)

80-35-3

DISCOVER
SULFANILAMIDE CRS (100 MG)

SULFANILAMIDE CRS (100 MG)

63-74-1

DISCOVER
SULFASALAZINE CRS (320 MG)

SULFASALAZINE CRS (320 MG)

599-79-1

DISCOVER
SULFASALAZINE DERIVATIVE FOR RESOLUTION CRS (20 MG)

SULFASALAZINE DERIVATIVE FOR RESOLUTION CRS (20 MG)

NA

DISCOVER
SULFATHIAZOLE CRS (100 MG)

SULFATHIAZOLE CRS (100 MG)

72-14-0

DISCOVER
SULFINPYRAZONE CRS (30 MG)

SULFINPYRAZONE CRS (30 MG)

57-96-5

DISCOVER
SULFINPYRAZONE IMPURITY A CRS(20 MG)

SULFINPYRAZONE IMPURITY A CRS(20 MG)

1106-50-9

DISCOVER